SCHEMBL8312206

SCHEMBL8312206

O=C(c1ccc(Nc2nccc(-c3ccc(S(=O)(=O)C4CCOCC4)cc3)n2)cc1)N1CCN(C(=O)c2ccco2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.50
SMG1 Q96Q15 1/20 0.50
JAK2 O60674 12/20 0.49
JAK3 P52333 6/20 0.47
JAK1 P23458 3/20 0.47
TYK2 P29597 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC3 O15379 1/20 0.47
NCOR1 O75376 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13590786 0.89 IKBKB (0.51) MTORSMG1JAK2JAK3JAK1
SCHEMBL8313895 0.88 JAK2 (0.54) MTORSMG1JAK2JAK3JAK1
SCHEMBL4071019 0.87 IKBKB (0.56) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL8312451 0.87 IKBKB (0.58) MTORSMG1JAK2JAK3JAK1
SCHEMBL14021396 0.86 IKBKB (0.56) MTORSMG1JAK2JAK3JAK1
SCHEMBL8314813 0.85 MTOR (0.54) MTORSMG1JAK2ALDH1A1LMNA
SCHEMBL8312956 0.85 TSHR (0.54) MTORSMG1JAK2ALDH1A1LMNA
SCHEMBL8313300 0.84 IKBKB (0.55) MTORSMG1JAK2JAK3IKBKB
SCHEMBL14021335 0.84 MTOR (0.51) MTORSMG1JAK2ALDH1A1LMNA
SCHEMBL8313348 0.83 SMG1 (0.48) MTORSMG1JAK2JAK3JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed